MariMed Inc. (PNK:MRMD) Q4 2022 Earnings Call Transcript

Page 4 of 4

Tim Shaw: Yes. So Massachusetts is definitely Nature’s has held in the high — in that state. Maryland, as you know, we just took over ownership of Kind Therapeutics. There was a few years that we didn’t have the controls in that market, and we lost some market share. However, the brand is clawing its way back to top tier in the state, and we look forward to adult use coming on board, and we are very confident we’ll be back in the top tier this year.

Jon Decourcey: Okay, great. I’ll hop back in the queue.

Operator: Thank you. There are no further questions at this time. Ladies and gentlemen, this does conclude your conference call for today. We thank you for your participation and ask that you please disconnect your lines.

Jon Levine: Thank you.

Follow Marimed Inc.

Page 4 of 4